Header Logo

Connection

Kabirullah Lutfy to Drug Tolerance

This is a "connection" page, showing publications Kabirullah Lutfy has written about Drug Tolerance.
Connection Strength

1.283
  1. Differential involvement of enkephalins in analgesic tolerance, locomotor sensitization, and conditioned place preference induced by morphine. Behav Neurosci. 2006 Feb; 120(1):10-5.
    View in: PubMed
    Score: 0.251
  2. Orphanin FQ/nociceptin attenuates the development of morphine tolerance in rats. Br J Pharmacol. 2001 Oct; 134(3):529-34.
    View in: PubMed
    Score: 0.186
  3. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test. Brain Res. 1996 Aug 26; 731(1-2):171-81.
    View in: PubMed
    Score: 0.131
  4. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence. Neuroscience. 2016 08 04; 329:318-25.
    View in: PubMed
    Score: 0.128
  5. Morphine analgesia and tolerance in mice selectively bred for divergent swim stress-induced analgesia. Eur J Pharmacol. 1994 Nov 24; 265(3):171-4.
    View in: PubMed
    Score: 0.116
  6. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation. Brain Res. 1990 Oct 08; 529(1-2):143-8.
    View in: PubMed
    Score: 0.087
  7. Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats. Psychopharmacology (Berl). 2002 Nov; 164(2):168-76.
    View in: PubMed
    Score: 0.050
  8. Sensitization does not develop to cocaine-induced potentiation of the antinociceptive effect of morphine. Brain Res Bull. 2002 May; 58(1):7-12.
    View in: PubMed
    Score: 0.048
  9. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance. Eur J Pharmacol. 1999 Nov 12; 384(1):1-5.
    View in: PubMed
    Score: 0.041
  10. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine. Pharmacol Res. 1999 Nov; 40(5):435-42.
    View in: PubMed
    Score: 0.041
  11. Tolerance develops to the inhibitory effect of orphanin FQ on morphine-induced antinociception in the rat. Neuroreport. 1999 Jan 18; 10(1):103-6.
    View in: PubMed
    Score: 0.039
  12. Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, a NMDA receptor antagonist, in the formalin and rotarod test in mice. Pharmacol Res. 1998 Apr; 37(4):295-302.
    View in: PubMed
    Score: 0.037
  13. Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist. Eur J Pharmacol. 1995 Jan 24; 273(1-2):187-9.
    View in: PubMed
    Score: 0.029
  14. ACEA-1011, a novel NMDA receptor/glycine site antagonist, produces antinociception but not tolerance in the formalin test in mice. NIDA Res Monogr. 1995; 147:220-33.
    View in: PubMed
    Score: 0.029
  15. Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 1993 Jul 09; 616(1-2):83-8.
    View in: PubMed
    Score: 0.026
  16. The role of opioid receptor density in morphine tolerance. J Pharmacol Exp Ther. 1991 Feb; 256(2):575-80.
    View in: PubMed
    Score: 0.022
  17. Sensitization to cocaine after a single intra-cerebral injection of orphanin FQ/nociceptin. Behav Brain Res. 2002 Apr 01; 131(1-2):97-103.
    View in: PubMed
    Score: 0.012
  18. Tolerance develops to spinal morphine analgesia but not morphine-induced convulsions. Eur J Pharmacol. 1990 Jan 25; 176(1):63-7.
    View in: PubMed
    Score: 0.005
  19. Differentiation of spinal and supraspinal opioid receptors by morphine tolerance. Life Sci. 1990; 46(5):343-50.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.